Top View
- Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
- The Role of Cocaine- and Amphetamine-Regulated Transcript in Endocrine Cells Shcherbina, Liliya
- (Therapeutic Products) Regulations 2015
- 2020 Equine Prohibited Substances List
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Swine Anesthesia and Analgesia, 2000-2010
- List of Common Prohibited Substance for the California Equine Medication
- Transdermal Device Containing
- NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
- FEI Prohibited Substances List the 2011 List of FEI Prohibited Substances Will Come Into Effect on 4 April 2011
- Example List of Forbidden Substances
- 2012 Equine Prohibited Substances List
- Appendix of Drugs *
- Drugs and Medications
- (12) United States Patent (10) Patent No.: US 8,652,511 B2 Cottrell Et Al
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
- 2020 AQHA Guidelines and Rules for Drugs and Medications
- Sleep Apnea and CMV Driver Safety
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Association of Hydroxylmethyl Glutaryl Coenzyme a Reductase Inhibitors
- Reboxetine Enhances the Olanzapine-Induced Antipsychotic-Like Effect, Cortical Dopamine Outflow and NMDA Receptor-Mediated Transmission
- Laboratory Animal Anaesthesia, Third Edition
- Antipsychotics for Treatment of Delirium in Hospitalised Non-ICU Patients
- (12) United States Patent (10) Patent No.: US 7,026,360 B1 Fest0 (45) Date of Patent: Apr
- FEI EPSL Banned Substances, 25 November 2019
- APPENDIX #2 Proposed Penalty Changes for Class 2 Substances